Atara Biotherapeutics Inc. (ATRA) Fundamentals

Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. The company's product candidates comprise Tab-cel, ATA188, and CAR T Programs.
SHARE INFORMATION
Market Cap$ 438,072,855
Shares Outstanding93,405,726
Float91,033,180
Percent Float97.46%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 20,340,000
Latest Fiscal EPS$ -3.63
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions340
Institutional Holdings Date2022-07-31
Institutional Bought Previous 3 Months9,805,513
Institutional Holdings Percent63.8%
Institutional Sold Previous 3 Months6,564,761
Insider Holdings Date2022-07-31
Insider Bought Previous 3 Months520,000
Insider Holdings Percent3.3
Insider Sold Previous 3 Months46,664
Insider Shares Owned3,044,117
TRADING INFO
52 Week High$ 20.04
52 Week Low$ 2.83
52 Week High Change$ -62.45
21 Day Moving Average$ 3.7238
21 Day Extended Moving Average$ 4.0556
50 Day Moving Average$ 5.2986
50 Day Extended Moving Average$ 5.0858
200 Day Moving Average$ 10.7674
200 Day Extended Moving Average$ 9.1933
10 Day Average Volume3,278,212
20 Day Average Volume4,178,377
30 Day Average Volume3,276,700
50 Day Average Volume2,475,862
Alpha-0.006959
Beta1.0761
Standard Deviation0.261302
R20.042427
7 Day Price Change$ 1.72
7 Day Percent Change57.91%
21 Day Price Change$ 1.05
21 Day Percent Change28.85%
30 Day Price Change$ -3.81
30 Day Percent Change-44.82%
Month to Date Price Change$ 1.66
Month to Date Percent Change54.79%
Quarter to Date Price Change$ -3.10
Quarter to Date Percent Change-39.79%
180 Day Price Change$ -11.04
180 Day Percent Change-70.18%
200 Day Price Change$ -9.30
200 Day Percent Change-66.48%
Year to Date Price Change$ -11.07
Year to Date Percent Change-70.24%

Atara Biotherapeutics Inc. (ATRA) Key Ratios

PROFITABILITY
EBIT Margin-1,454.0%
EBITDA Margin-1,417.8%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 20,232,000
Revenue Per Share$ 0.2144
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book1.50
Total Debt To Equity0.10
Int Coverage0.00
Current Ratio3.10
Leverage Ratio1.70
Quick Ratio3.00
Long Term Debt To Capital0.07
VALUATION MEASURES
PE Ratio-1.00
Enterprise Value$ 54,704,785
Price to Sales21.8742
Price to Free Cash-1.80
PE High Last 5 Years-4.90
Price To Book1.50
Price To Cash Flow0.00
PE Low Last 5 Years-4.30
Price to Tangible Book1.50
MANAGEMENT EFFECTIVENESS
Receivables Turnover22.40
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-77.98
Return on Equity-116.42
Return on Capital-107.11

Atara Biotherapeutics Inc. (ATRA) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorDeloitte & Touche LLP
CEOPascal Touchon
Emplyoees570
Last AuditUQ
CIK0001604464
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address611 Gateway Boulevard
Suite 900
South San Francisco, CA 94080
Websitehttps://www.atarabio.com
Facsimile-
Telephone+1 650 278-8930
Emailjcraighead@atarabio.com


Your Recent History
NASDAQ
ATRA
Atara Biot..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.